{
  "resourceType": "ValueSet",
  "id": "2.16.840.1.113883.3.526.3.402",
  "meta": {
    "versionId": "25",
    "lastUpdated": "2022-03-02T18:05:36.000-05:00"
  },
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.3.402",
  "version": "20170908",
  "name": "Influenza Vaccination",
  "status": "active",
  "date": "2022-03-03T18:46:01-05:00",
  "publisher": "NCQA PHEMUR",
  "compose": {
    "include": [
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1761"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.199"
        ]
      },
      {
        "valueSet": [
          "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.526.2.1351"
        ]
      }
    ]
  },
  "expansion": {
    "identifier": "urn:uuid:346f44fc-6621-468d-87f8-25e9dfba68da",
    "timestamp": "2022-06-10T08:49:11-04:00",
    "total": 30,
    "offset": 0,
    "parameter": [
      {
        "name": "count",
        "valueInteger": 1000
      },
      {
        "name": "offset",
        "valueInteger": 0
      }
    ],
    "contains": [
      {
        "system": "http://snomed.info/sct",
        "version": "http://snomed.info/sct/731000124108/version/20220301",
        "code": "86198006",
        "display": "Administration of vaccine product containing only Influenza virus antigen (procedure)"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90630",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, for intradermal use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90653",
        "display": "Influenza vaccine, inactivated (IIV), subunit, adjuvanted, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90654",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative-free, for intradermal use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90655",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90656",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90657",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90658",
        "display": "Influenza virus vaccine, trivalent (IIV3), split virus, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90661",
        "display": "Influenza virus vaccine, trivalent (ccIIV3), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90662",
        "display": "Influenza virus vaccine (IIV), split virus, preservative free, enhanced immunogenicity via increased antigen content, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90666",
        "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, preservative free, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90667",
        "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, adjuvanted, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90668",
        "display": "Influenza virus vaccine (IIV), pandemic formulation, split virus, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90673",
        "display": "Influenza virus vaccine, trivalent (RIV3), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90674",
        "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, preservative and antibiotic free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90682",
        "display": "Influenza virus vaccine, quadrivalent (RIV4), derived from recombinant DNA, hemagglutinin (HA) protein only, preservative and antibiotic free, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90685",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90686",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90687",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90688",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), split virus, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90689",
        "display": "Influenza virus vaccine, quadrivalent (IIV4), inactivated, adjuvanted, preservative free, 0.25 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90694",
        "display": "Influenza virus vaccine, quadrivalent (aIIV4), inactivated, adjuvanted, preservative free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.ama-assn.org/go/cpt",
        "version": "2021",
        "code": "90756",
        "display": "Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "G0008",
        "display": "Administration of influenza virus vaccine"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "Q2034",
        "display": "Influenza virus vaccine, split virus, for intramuscular use (agriflu)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "Q2035",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "Q2036",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "Q2037",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "Q2038",
        "display": "Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)"
      },
      {
        "system": "http://www.nlm.nih.gov/research/umls/hcpcs",
        "version": "2022",
        "code": "Q2039",
        "display": "Influenza virus vaccine, not otherwise specified"
      }
    ]
  }
}